Maprotiline for disordered cognitive function in Parkinson's disease.
D000873:Anthracenes / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000627:therapeutic use*; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications*
D000873:Anthracenes; D008376:Maprotiline